Healthcare & Pharmaceuticals

Healthcare & Pharmaceuticals in Iraq

Etihad Law Firm advises healthcare providers, pharmaceutical companies, medical device manufacturers, investors, and government authorities across the full spectrum of healthcare and pharmaceutical legal matters in Iraq. As Iraq’s healthcare sector undergoes significant expansion and modernisation driven by population growth, increased government spending, and growing private sector participation, we provide the legal expertise that enables our clients to enter, operate, and grow within one of the region’s most complex and heavily regulated industries.

Healthcare and pharmaceuticals in Iraq sit at the intersection of public interest and commercial opportunity. The regulatory requirements are demanding, the institutional landscape is multi-layered, and the consequences of non-compliance are severe. Our role is to ensure that our clients navigate this environment with confidence structuring their operations correctly from the outset, maintaining compliance as regulations evolve, and protecting their interests when disputes or regulatory challenges arise.

Core Services

Regulatory Licensing and Market Entry Entering Iraq’s healthcare and pharmaceutical market requires navigating a complex web of regulatory approvals involving multiple authorities, including the Ministry of Health, the Iraqi Drug and Medical Supplies Authority, and relevant provincial health directorates. We advise clients on the full range of licensing and registration requirements applicable to their operations whether they are establishing a private hospital, registering a pharmaceutical product, importing medical devices, or setting up a distribution network. We manage regulatory submissions on behalf of our clients, engage with the relevant authorities throughout the approval process, and provide clear guidance on the conditions and obligations attached to licences and registrations once granted.

Pharmaceutical Product Registration The registration of pharmaceutical products in Iraq involves detailed regulatory procedures administered by the Ministry of Health, with requirements covering product dossiers, clinical data, manufacturing standards, and labelling compliance. We assist pharmaceutical manufacturers and distributors in preparing and submitting registration applications, managing correspondence with regulatory authorities, and addressing queries or objections raised during the review process. We also advise on the legal implications of changes to registered products including formulation changes, manufacturing site variations, and updates to product information and on the regulatory pathway for generics and biosimilars.

Healthcare Investment Structuring Iraq’s healthcare sector presents substantial investment opportunities, particularly in private hospital development, diagnostic services, specialist clinics, and pharmaceutical manufacturing. We advise domestic and international investors on the structuring of healthcare investments in compliance with Iraq’s investment law framework, including the obtaining of investment licences from the National Investment Commission, the structuring of joint ventures and partnerships with Iraqi entities, and the design of corporate and operational structures that are both legally compliant and commercially optimised. We work closely with our clients’ commercial teams to ensure that investment structures are built for long-term operational success in the Iraqi market.

Healthcare Facility Licensing and Operational Compliance Operating a healthcare facility in Iraq whether a hospital, clinic, diagnostic centre, or specialised treatment facility requires compliance with a detailed framework of licensing, staffing, equipment, and operational standards set by the Ministry of Health and relevant provincial authorities. We advise healthcare operators on the full range of licensing requirements applicable to their facilities, assist in preparing licensing applications and supporting documentation, and provide ongoing compliance advice as regulatory requirements evolve. We also advise on the legal implications of inspections, audit findings, and regulatory enforcement actions, and we represent clients in proceedings before health regulatory authorities where required.

Medical Device and Equipment Regulation The importation, registration, and commercialisation of medical devices and equipment in Iraq is subject to regulatory oversight by the Ministry of Health and customs authorities. We advise medical device manufacturers, importers, and distributors on the regulatory framework applicable to their products, including registration requirements, import procedures, technical standards compliance, and post-market obligations. We assist clients in structuring their distribution arrangements effectively and in managing the regulatory risks associated with their product portfolios in the Iraqi market.

Pharmaceutical Distribution and Supply Chain Agreements We draft and negotiate a broad range of commercial agreements for the pharmaceutical and healthcare sectors, including distribution agreements, agency arrangements, supply contracts, manufacturing and licensing agreements, and procurement contracts. Our team ensures that agreements are carefully structured to reflect the regulatory environment in which they operate addressing issues such as product liability, regulatory compliance obligations, exclusivity arrangements, pricing controls, and the allocation of risk between the parties.

Healthcare Public-Private Partnerships The Iraqi government has identified private sector participation in healthcare as a strategic priority, with a growing pipeline of public-private partnership opportunities in hospital construction, facility management, and specialist healthcare services. We advise both government authorities and private sector partners on the legal structuring of healthcare PPP arrangements, including concession agreements, service contracts, facility management agreements, and the regulatory approvals required to implement PPP structures in the health sector. Our team has experience in aligning PPP frameworks with Iraq’s investment law and procurement regulations, and we work to ensure that arrangements are bankable, operationally sound, and legally robust.

Intellectual Property in the Pharmaceutical Sector Intellectual property protection is a critical commercial consideration for pharmaceutical companies operating in Iraq, covering patent rights in respect of innovative products, trademark protection for pharmaceutical brands, and the management of data exclusivity rights. We advise pharmaceutical clients on IP protection strategies in Iraq, including the registration and enforcement of patents and trademarks, the structuring of licensing arrangements, and the management of IP risks arising from generic competition and parallel imports. We also advise on the interface between IP rights and Iraq’s regulatory framework for pharmaceutical product registration.

Healthcare Disputes and Regulatory Enforcement Disputes in the healthcare and pharmaceutical sector arise in a variety of contexts including regulatory enforcement actions, commercial contract disputes between healthcare providers and suppliers, product liability claims, and disputes between healthcare facilities and patients or their families. We represent clients across the full range of healthcare disputes, advising on dispute resolution strategy and providing experienced legal representation in negotiations, regulatory proceedings, arbitration, and litigation before Iraqi courts. Where clients face regulatory investigations or enforcement actions by the Ministry of Health or other public authorities, we provide immediate legal support and strategic advice to manage the process effectively and protect our clients’ interests.

Anti-Corruption and Compliance in Healthcare The healthcare sector in Iraq given its significant public funding and the central role of government procurement is an area of heightened compliance risk. We advise pharmaceutical companies, medical device suppliers, and healthcare providers on anti-corruption compliance in the context of their interactions with public health authorities and government procurement processes. We assist clients in designing and implementing compliance programmes tailored to the healthcare sector, conducting compliance reviews, and managing regulatory risk arising from the Integrity Commission’s oversight of public procurement and anti-corruption enforcement.

Why Etihad Law Firm

We work with a broad range of clients across the healthcare and pharmaceutical sectors, including private hospitals and clinics, pharmaceutical manufacturers and distributors, medical device and equipment suppliers, healthcare investors and private equity funds, international healthcare groups entering the Iraqi market, government ministries and public health authorities, and insurance companies operating in the health sector.

We have advised clients across the full spectrum of healthcare and pharmaceutical matters in Iraq from market entry and product registration through to investment structuring, commercial contracting, compliance management, and dispute resolution. Our lawyers understand the regulatory framework that governs the sector in depth, and we maintain strong working relationships with the Ministry of Health and other relevant authorities, enabling us to engage effectively on behalf of our clients and to provide reliable, current guidance on regulatory developments as they arise.

We are trusted by our clients including international pharmaceutical groups, private healthcare investors, medical device companies, and healthcare facility operators because we understand the particular challenges of operating in Iraq’s healthcare sector and we deliver advice that is legally rigorous, commercially grounded, and genuinely useful.